These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 35690143)
1. Neural stem cell secretome exerts a protective effect on damaged neuron mitochondria in Parkinson's disease model. Ni W; Zhou J; Ling Y; Lu X; Niu D; Zeng Y; Qiu Y; Si Y; Wang J; Zhang W; Wang Z; Hu J Brain Res; 2022 Sep; 1790():147978. PubMed ID: 35690143 [TBL] [Abstract][Full Text] [Related]
2. Neural stem cells transplantation combined with ethyl stearate improve PD rats motor behavior by promoting NSCs migration and differentiation. Huang J; Yi L; Yang X; Zheng Q; Zhong J; Ye S; Li X; Li H; Chen D; Li C CNS Neurosci Ther; 2023 Jun; 29(6):1571-1584. PubMed ID: 36924304 [TBL] [Abstract][Full Text] [Related]
3. Secretome of Undifferentiated Neural Progenitor Cells Induces Histological and Motor Improvements in a Rat Model of Parkinson's Disease. Mendes-Pinheiro B; Teixeira FG; Anjo SI; Manadas B; Behie LA; Salgado AJ Stem Cells Transl Med; 2018 Nov; 7(11):829-838. PubMed ID: 30238668 [TBL] [Abstract][Full Text] [Related]
4. Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7. Inden M; Kitamura Y; Takahashi K; Takata K; Ito N; Niwa R; Funayama R; Nishimura K; Taniguchi T; Honda T; Taira T; Ariga H J Pharmacol Sci; 2011; 117(3):189-203. PubMed ID: 22041943 [TBL] [Abstract][Full Text] [Related]
5. ALCAR Exerts Neuroprotective and Pro-Neurogenic Effects by Inhibition of Glial Activation and Oxidative Stress via Activation of the Wnt/β-Catenin Signaling in Parkinsonian Rats. Singh S; Mishra A; Shukla S Mol Neurobiol; 2016 Sep; 53(7):4286-301. PubMed ID: 26223802 [TBL] [Abstract][Full Text] [Related]
6. Preclinical Comparison of Stem Cells Secretome and Levodopa Application in a 6-Hydroxydopamine Rat Model of Parkinson's Disease. Teixeira FG; Vilaça-Faria H; Domingues AV; Campos J; Salgado AJ Cells; 2020 Jan; 9(2):. PubMed ID: 32012897 [TBL] [Abstract][Full Text] [Related]
7. Effects of (-)-sesamin on 6-hydroxydopamine-induced neurotoxicity in PC12 cells and dopaminergic neuronal cells of Parkinson's disease rat models. Park HJ; Zhao TT; Lee KS; Lee SH; Shin KS; Park KH; Choi HS; Lee MK Neurochem Int; 2015; 83-84():19-27. PubMed ID: 25747493 [TBL] [Abstract][Full Text] [Related]
8. Allogeneic/xenogeneic transplantation of peptide-labeled mitochondria in Parkinson's disease: restoration of mitochondria functions and attenuation of 6-hydroxydopamine-induced neurotoxicity. Chang JC; Wu SL; Liu KH; Chen YH; Chuang CS; Cheng FC; Su HL; Wei YH; Kuo SJ; Liu CS Transl Res; 2016 Apr; 170():40-56.e3. PubMed ID: 26730494 [TBL] [Abstract][Full Text] [Related]
9. Trib3 Is Elevated in Parkinson's Disease and Mediates Death in Parkinson's Disease Models. Aimé P; Sun X; Zareen N; Rao A; Berman Z; Volpicelli-Daley L; Bernd P; Crary JF; Levy OA; Greene LA J Neurosci; 2015 Jul; 35(30):10731-49. PubMed ID: 26224857 [TBL] [Abstract][Full Text] [Related]
10. The Parkinson's disease-related protein DJ-1 protects dopaminergic neurons in vivo and cultured cells from alpha-synuclein and 6-hydroxydopamine toxicity. Batelli S; Invernizzi RW; Negro A; Calcagno E; Rodilossi S; Forloni G; Albani D Neurodegener Dis; 2015; 15(1):13-23. PubMed ID: 25500798 [TBL] [Abstract][Full Text] [Related]
11. PARK7 DJ-1 protects against degeneration of nigral dopaminergic neurons in Parkinson's disease rat model. Inden M; Taira T; Kitamura Y; Yanagida T; Tsuchiya D; Takata K; Yanagisawa D; Nishimura K; Taniguchi T; Kiso Y; Yoshimoto K; Agatsuma T; Koide-Yoshida S; Iguchi-Ariga SM; Shimohama S; Ariga H Neurobiol Dis; 2006 Oct; 24(1):144-58. PubMed ID: 16860563 [TBL] [Abstract][Full Text] [Related]
12. Cotransplantation of NSCs and ethyl stearate promotes synaptic plasticity in PD rats by Drd1/ERK/AP-1 signaling pathway. Yi L; Ma H; Yang X; Zheng Q; Zhong J; Ye S; Li X; Chen D; Li H; Li C J Ethnopharmacol; 2024 Mar; 321():117292. PubMed ID: 37806537 [TBL] [Abstract][Full Text] [Related]
13. Long-Term Voluntary Physical Exercise Exerts Neuroprotective Effects and Motor Disturbance Alleviation in a Rat Model of Parkinson's Disease. Tsai WL; Chen HY; Huang YZ; Chen YH; Kuo CW; Chen KY; Hsieh TH Behav Neurol; 2019; 2019():4829572. PubMed ID: 31885725 [TBL] [Abstract][Full Text] [Related]
14. Identification of bilateral changes in TID1 expression in the 6-OHDA rat model of Parkinson's disease. Proft J; Faraji J; Robbins JC; Zucchi FC; Zhao X; Metz GA; Braun JE PLoS One; 2011; 6(10):e26045. PubMed ID: 22016808 [TBL] [Abstract][Full Text] [Related]
15. Impact of Aging on the 6-OHDA-Induced Rat Model of Parkinson's Disease. Barata-Antunes S; Teixeira FG; Mendes-Pinheiro B; Domingues AV; Vilaça-Faria H; Marote A; Silva D; Sousa RA; Salgado AJ Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32422916 [TBL] [Abstract][Full Text] [Related]
16. Secretome released from hydrogel-embedded adipose mesenchymal stem cells protects against the Parkinson's disease related toxin 6-hydroxydopamine. Chierchia A; Chirico N; Boeri L; Raimondi I; Riva GA; Raimondi MT; Tunesi M; Giordano C; Forloni G; Albani D Eur J Pharm Biopharm; 2017 Dec; 121():113-120. PubMed ID: 28965958 [TBL] [Abstract][Full Text] [Related]
17. Dopamine receptor activation mitigates mitochondrial dysfunction and oxidative stress to enhance dopaminergic neurogenesis in 6-OHDA lesioned rats: A role of Wnt signalling. Mishra A; Singh S; Tiwari V; Chaturvedi S; Wahajuddin M; Shukla S Neurochem Int; 2019 Oct; 129():104463. PubMed ID: 31078578 [TBL] [Abstract][Full Text] [Related]
18. Reduced dopaminergic neuron degeneration and global transcriptional changes in Parkinson's disease mouse brains engrafted with human neural stems during the early disease stage. Pereira MCL; Boese AC; Murad R; Yin J; Hamblin MH; Lee JP Exp Neurol; 2022 Jun; 352():114042. PubMed ID: 35271839 [TBL] [Abstract][Full Text] [Related]
19. Engrafted primary type-2 astrocytes improve the recovery of the nigrostriatal pathway in a rat model of Parkinson's disease. Sun Y; Lu XJ; Fu X; Zhang Y; Zhan Y; Liu J; Zhao L; Xia CL Mol Cell Biochem; 2021 Feb; 476(2):619-631. PubMed ID: 33070275 [TBL] [Abstract][Full Text] [Related]
20. Research progress of neural stem cells as a source of dopaminergic neurons for cell therapy in Parkinson's disease. Zhang L; Yang H Mol Biol Rep; 2024 Feb; 51(1):347. PubMed ID: 38400887 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]